Lilly Officially Pleads Guilty In Zyprexa Debacle

By Erin Marie Daly

Law360, New York (January 30, 2009, 12:00 AM ET) -- Weeks after Eli Lilly & Co. announced a record-breaking $1.4 billion deal to settle charges that it illegally marketed its anti-psychotic treatment Zyprexa for off-label use, the pharmaceutical giant formally pled guilty Friday to a misdemeanor related to the scandal.

The U.S. Attorney's Office for the Eastern District of Pennsylvania said Lilly — which had already agreed to the plea — officially pled guilty at a hearing in federal court in Philadelphia to “the introduction into interstate commerce of quantities of its drug, Zyprexa, that were...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles